Pharmaceutical Manufacturing and Fill-Finish Services

The contract involves the manufacturing and fill-finish services for Maropitant Citrate at a concentration of 10mg/mL, packaged in 20mL vials. The scope covers the full process from formulation through sterile filling, capping, and comprehensive batch testing, all conducted under current Good Manufacturing Practice (cGMP) standards to ensure quality and compliance. This subcontract falls under the pharmaceutical manufacturing sector, specifically NAICS code 325412. The work is solicited by the Department of Defense's Medical Supply Chain Pharmaceutical FSA, with performance located in San Antonio, Texas (ZIP code 78226). The contract timeline includes a solicitation posting date of May 17, 2026, with proposals due by May 26, 2026. This contract supports the Department of Defense’s supply chain needs for pharmaceutical products requiring stringent sterile processing and quality assurance.